Merck Serono
Who we are
What we do
How we innovate
Clinical Trials
The Merck Group
Therapeutic Areas
Oncology
Neurodegenerative Diseases
Fertility
Endocrinology
CardioMetabolic Care
New Specialist Therapies
Media
News Releases
Facts and Figures
Careers
Working in the Merck Group
Careers Areas
Local Employer
Merck Serono
Job Center
Partnering
What We Offer
What We Seek
How We Work Together
Your Submission
Home
Merck Group
Sitemap
Contacts
Merck Serono Websites
Search
Merck Serono is the division for innovative small molecules and
biopharmaceuticals of
Merck KGaA
.
Merck Serono’s global headquarters are located in Geneva,
Switzerland. In the United States and Canada, the division operates
as EMD Serono.
MERCK SHARE
01/12/2008 05:35 pm
63.20 EUR
-4.08
XETRA
Quotes by
Flife
DIVISION NEWS
2008/12/01
MERCK SERONO: EUROPEAN COMMISSION APPROVES ERBITUX FOR FIRST-LINE USE IN HEAD AN ...
2008/11/13
MERCK SERONO: OVERALL SURVIVAL IN FIRST-LINE NSCLC REACHES 15 MONTHS WITH ERBITU ...
2008/11/12
MERCK SERONO LAUNCHES EXPANSION OF FLAGSHIP BIOTECH CENTER TO MEET GROWING PATIE ...
All News Releases
SERVICES
Print Page
//SRC=“SDC-Server/SDCID
